An invitation to submit a tentative summary/manuscript to current special issues of different following journals. Please check the websites for publication fees and Author Guidelines.
Journal of Advanced Research (IF 6.99; Elsevier; original research as well as reviews) https://www.journals.elsevier.com/journal-of-advanced-research/call-for-papers/current-trends-in-management-of-dementia |
Thematic series of “International Journal of Nanomedicines” Topic: Role of Phenolic Nanocompounds in Inflammatory disorders: Current view and Future Aspects Keywords: Phenolic compounds, inflammation, Pro-inflammatory mediators, Natural products, Nanomedicines Title page information deadline in the email by subject heading, “IJNanom” : 5th Feb 2021 Manuscript submission deadline: 1st June 2021 There is no code associated with the papers – experts in the nano field may submit their manuscript at the following link: https://www.dovepress.com/submit_step_1.php |
Recent Advances of Evidence-Based Neuropsychology Frontiers in Psychology (Neuropsychology Section) https://www.frontiersin.org/research-topics/11656/recent-advances-of-evidence-based-neuropsychology |
Cytokine Storm and Amyloid Pathology Including Viral Infection in Neurological Infections https://www.hindawi.com/journals/mi/si/951327/ |
Biomedical informatics in neuroscience Section: Brain disorders Journal of Integrative Neuroscience https://jin.imrpress.com/EN/subject/listSubjectChapters.do?subjectId=1611653500838 |
Herbal drug targets for COVID-19, Type 2 Diabetes, and cancer(s) and possible linkage with each other https://benthamscience.com/journal-files/special-issue-details/CCHTS-SII20201230-01.pdf |
Phytomedicines, Current trends in natural products applications in the management of Lung Diseases, Rupesh K. Gautam, Shabana Bibi and Mohammad Amjad Kamal https://www.journals.elsevier.com/phytomedicine/call-for-papers/current-trends-in-natural-products-applications-in-the-mgmt |
Current Overview of implementing phytochemistry and nanotechnology for management of various health issues including COVID-19 https://www.editorialmanager.com/bab/default.aspx, Authors should select VSI: Viral infectious disease |
Title of the Thematic Issue: Critical appraisals on Neuron-Glia interactions in Neurological Disorders for the journal of “Current Neuropharmacology” https://mc04.manuscriptcentral.com/crn |
Special Issue for Current Medicinal Chemistry, Trends in computational approaches for anti-cancer research, https://benthamscience.com/journal-files/special-issue-details/CMC-SII20200914-01.pdf |
Medicinal Chemistry, "Insights on SARS-COVID-19 and its linkage with cancer using rational drug design: Bioactive compounds using computational approaches", https://benthamscience.com/journal-files/special-issue-details/MC-SII20200622-01.pdf |
Linkage of COVID-19 and Neurodegenerative disorders, "CNS & Neurological Disorders - Drug Targets", BMS-CNSNDDT-2020-HT-13 https://bentham.manuscriptpoint.com/submit/Submission/submissionForm/2018/m |
Journal: Coronaviruses Current research updates on Coronavirus Outbreak: Overviews of its global impact and consequences https://benthamscience.com/journal-files/special-issue-details/COVID-SII20200714-01.pdf, The thematic issue code is BMS-COVID-2020-HT-1, link for direct submission in the thematic issue: https://bentham.manuscriptpoint.com/submit/Submission/118341/1 |
Special issue in Current Medicinal Chemistry (IF ~4.2), Thematic issue proposal title: Targeting cellular signalling pathways in cancer by natural compounds, Manuscript submission deadline: 15th Oct 2020, BMS-CMC-2020-HT-36, [The contributors should be outstanding researchers (preferably with Scopus H-index 20)], https://benthamscience.com/journal-files/special-issue-details/CMC-SII20200619-02.pdf |
"Alzheimer Disease and Sleep Disorders; Insights into the Possible Disease Connections and the Potential Therapeutic Targets" for publication in "CNS & Neurological Disorders - Drug Targets", https://bentham.manuscriptpoint.com/submit/Submission/submissionForm/1663/m , Code of our special issue is BMS-CNSNDDT-2020-HT-12 |
Special Issue "How to Optimize the Use of Antibiotics in Human and Animal Health Care? – A Time to Act", https://www.mdpi.com/journal/antibiotics/special_issues/use_human_animal |
Research Topic proposal on 'Bioactive Compounds and Diabetes Mellitus: Prospects and Challenges' with Frontiers in Nutrition, https://www.frontiersin.org/research-topics/11702/bioactive-compounds-and-diabetes-mellitus-prospects-and-challenges |
"Synopsis on Antimicrobials Challenges—From Dentistry to Environmental Visions", https://www.mdpi.com/journal/antibiotics/special_issues/anti_challenges |
SI title: GUT Microbiota and Cardiovascular Pharmacology, Journal: Pharmacological Research (IF 5.6), (VSI : Microbiota & Cardiovascular Pharmacology), https://www.journals.elsevier.com/pharmacological-research |
Viral disease and natural products, with a particular focus on COVID-19, Current Pharmaceutical Design (CPD; IF 2.412), BMS-CPD-2020-HT-153 Manuscript submission deadline: 31 July 2020, https://bentham.manuscriptpoint.com/journals/CPD |
Stem Cell Transplantation Therapy in Neurological Disorders: Current Status and Future Directions for the journal of “Current Neuropharmacology, Submission link: https://mc04.manuscriptcentral.com/crn, https://benthamscience.com/journal-files/special-issue-details/CN-SII20200601-01.pdf |
“INTEGRATED NEURAL TECHNOLOGIES: SOLUTIONS BEYOND TOMORROW”, https://neuroscirn.org/2021v3i5/ |
Special Issue on ‘Overviews on Current Stem Cells Research for Neurological Therapy’ in Current Stem Cell Research & Therapy, Code for submission: BSP-CSCRT-2017-HT39 |
Special Issue on "From Oxidative Stress to Ageing via Lifestyle, Nutraceuticals, Polypharmacy and Neuro-Psychological Factors" in Oxidative Medicine and Cellular Longevity |
Special Issue on "Nonpharmacologic Interventions in Prevention and Treatment of Hypertension" in International Journal of Hypertension |
Research Topic on The Alzheimer's Disease Challenge for Frontiers in Neuroscience, section Neurodegeneration http://journal.frontiersin.org/researchtopic/5903/the-alzheimers-disease-challenge |
Seminars in Cancer Biology (SCB); Title of the Special Issue: Current Vision on Target Enzymes for Cancer Therapy |
Research Topic of Frontiers in Aging Neuroscience: Neuroscientific Research for Management of Dementia |
Metabolic & Immune Disorders - Drug Targets dedicated on Current Vision of Systemic Autoimmune Diseases - From Diagnosis to Management http://benthamscience.com/journal-files/special-issue-details/EMIDDT-SII20160725-01.pdf |
Current Drug Metabolism (CDM), dedicated on Nanomedicines in cancer therapy: Advances and challenges Guest Editor(s): Sohail Akhter, Ziyaur Rahman, Mohammad A. Kamal, Ponnurengam M. Sivakumar) http://benthamscience.com/journals/current-drug-metabolism/special-issues/#top |
Current Drug Metabolism (CDM), dedicated on Frontier research view on drug discoveries for different diseases http://benthamscience.com/journals/current-drug-metabolism/special-issues/#top, use this code at the time of submission: BSP-CDM-2016-HT8 |
CNS & Neurological Disorders - Drug Targets SI-6 (CNSND-DT) dedicated on Association of CNS disorders with other health issues; Reference code for submission online: BSP-CDTCNSND-2015-HT27 http://benthamscience.com/journal/index.php?journalID=cnsnddt |
Current Aging Science dedicated on Current updates on understanding the purpose and mechanism of Aging http://www.benthamscience.com/journal/index.php?journalID=cas, Code of our thematic issue: BSP-CAS-2014-HT2 |